This trial includes the evaluation of daily grapefruit consumption over 6 weeks and its role in weight control and cardiometabolic risk factor modification. Additionally, the study includes an evaluation of the effects of added grapefruit on post-prandial inflammatory and oxidant stress response to a high-fat diet. This study received funding from the National Cancer Institute of the National Institutes of Health.